Silvie R. Bloudickova - Publications

Atrasentan: new molecule in the therapy of IgA nephropathy and other glomerulopathies.

Journal: Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti

Published: June 23, 2026

Beyond complement: comprehensive assessment of factor XIII plasma dynamics and genetics in atypical hemolytic uremic syndrome.

Journal: Research and practice in thrombosis and haemostasis

Published: April 18, 2026

Corrigendum to "Improving the histologic detection of donor-specific antibody-negative antibody-mediated rejection in kidney transplants" [American Journal of Transplantation Volume 26, Issue 1, January 2026, Pages 117-130].

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: April 17, 2026

Impact of older donor age in kidney transplants in a biopsy-based observational study.

Journal: JCI insight

Published: December 29, 2025

Improving the histologic detection of donor-specific antibody-negative antibody-mediated rejection in kidney transplants.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: June 02, 2025

Subthreshold rejection activity in many kidney transplants currently classified as having no rejection.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: May 08, 2024

Cardiovascular disease and kidney transplantation.

Journal: Vnitrni lekarstvi

Published: October 12, 2023

MTHFR and HFE, but not preproghrelin and LBP, polymorphisms as risk factors for all-cause end-stage renal disease development.

Journal: Folia biologica

Published: May 03, 2014